The biopsychosocial
model provides a more thorough and comprehensive overview of CIPA or HSAN IV.
First of all, from the biological aspect, as mentioned in the earlier post on the cause of this disease, it is caused by mutation in gene NTKR1. This gene
mutation leads to dysfunction in nerve cells receptors which affects sensation
beyond temperature and pain. The main and only root to this disease is
biological as it is related to gene mutation. Besides the root to this disease,
another aspect from the biological factor is genetic testing. It is advisable
for parents to undergo genetic testing as a precaution to rule out any
possibility of inheriting the disease and passing it down to their offspring.
This can be done before and after marriage, and also before conceiving a baby.
Moving on to the psychological factor, people with CIPA
need psycho-social support from people around them, for instance family and
friends, and also from the neighborhood. Other than that, as they get older,
they may need to seek for counseling to understand better and accept their
condition. Psychological aspect is not only limited to CIPA patients, their
parents will also require emotional support from others, especially when they
find out that their child has the disease. This is because it can be very
difficult to take care of a child with CIPA as many complications may
occur along the way.
Lastly, from the social aspect of biopsychosocial model,
it is likely that people with CIPA may face discrimination because they are
different from others and people might not understand them. Other people might
not be aware of this disease as CIPA is a rare disease which has a very low
occurrence. Furthermore, people with CIPA may also distant themselves from
social situations due to the fear of unintentionally harming themselves with
possible injury. This can be very dangerous and even fatal as they are not
alert of physical pain.
By looking through CIPA from the biopsychosocial model,
we can clearly visualize this disease at different perspectives and how a CIPA
patient is affected in different ways.
Reference:
Natural Organization for Rare Disorders. (2014). Hereditary sensory and autonomic neuropathy type iv. National Organization for Rare Disorders. Retrieved 13 October, 2013 from https://rarediseases.org/rare-diseases/hereditary-sensory-and-autonomic-neuropathy-type-iv/
Reference:
Natural Organization for Rare Disorders. (2014). Hereditary sensory and autonomic neuropathy type iv. National Organization for Rare Disorders. Retrieved 13 October, 2013 from https://rarediseases.org/rare-diseases/hereditary-sensory-and-autonomic-neuropathy-type-iv/
No comments:
Post a Comment